Cytogenetic and molecular cytogenetic investigations in relapse of B-cell chronic lymphocytic leukemia


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

Сhromosomal abnormalities have been analyzed in bone marrow cells of 61 patients with relapse of B-cell chronic lymphocytic leukemia. The cytogenetic results have allowed the structural stratification of the obtained karyotypes into ten groups of clones: normal, normal/near tetraploid, abnormal/normal, abnormal/ near tetraploid/normal, evolution of clonal chromosome abnormalities; evolution of clonal chromosome abnormalities/normal, evolution of clonal chromosome abnormalities/near tetraploid/normal, independent clones, independent/normal clones; and independent/near tetraploid/normal clones. The identified structural rearrangements included translocations, deletions, insertions, and duplications; however, deletions with the involvement of bands 17p12, 13q12–q14, 11q14, and 11q23 dominated (63.8%). The application of i-FISH helped to show the presence of one to four abnormalities per karyotype. The identified cytogenetic and molecular cytogenetic rearrangements may signify a multilevel nature of the process underlying the development of resistant karyotypes. The results obtained under both methods have revealed the presence of a heterogenic cell population with possibly different levels of chemotherapy resistance.

Sobre autores

S. Andreieva

Institute of Hematology and Transfusiology

Autor responsável pela correspondência
Email: office@immd.kiev.ua
Ucrânia, Kyiv

K. Korets

Scientific-Practical Children’s Cardiac Center

Email: office@immd.kiev.ua
Ucrânia, Kyiv

I. Skorokhod

Scientific-Practical Children’s Cardiac Center

Email: office@immd.kiev.ua
Ucrânia, Kyiv

O. Ruzhinska

Scientific-Practical Children’s Cardiac Center

Email: office@immd.kiev.ua
Ucrânia, Kyiv

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Allerton Press, Inc., 2017